Several clinical studies reported that Dickkopf1 (DKK1) plasma levels are correlated with atherosclerosis. However, the impact of DKK1 on the formation and vulnerability of atherosclerotic plaques remains elusive. This study investigated DKK1's effects on enlargement and destabilization of plaques by targeting endothelial cells and assessing the possible cellular mechanisms involved. The effects of DKK1 on atherogenesis and plaque stability were evaluated in ApoE − / − mice using lentivirus injections to knockdown and knock-in the DKK1 gene. The presence of DKK1 resulted in enlarged and destabilized atherosclerotic lesions and increased apoptosis, while silencing of DKK1 alleviated plaque formation and vulnerability in the whole progression of atherosclerosis. DKK1 expression was upregulated in response to ox-LDL treatment in a time-and concentration-dependent manner on human umbilical vein endothelial cell (HUVEC). The interference of DKK1 reversed ox-LDL-induced apoptosis in HUVECs. The mechanism underlying this effect was DKK1's activation of the JNK signal transduction pathway and inhibition of canonical Wnt signaling, following by activation of the IRE1α and eif2α/CHOP pathways. In conclusion, DKK1 promotes plaque formation and vulnerability partly by inducing apoptosis in endothelial cells, which partly through inducing the JNK-endoplasmic reticulum stress pathway and inhibiting canonical Wnt signaling. Cell Death and Disease (2017) 8, e2917; doi:10.1038/cddis.2017.277; published online 13 July 2017
Recent studies have found that acute coronary syndrome (ACS) is associated with both the sudden rupture of atherosclerotic plaques and the rapid development of these plaques. While atherogenesis remains incompletely understood, studies of atherogenesis pathology suggest that multiple cellular malfunctions, including endothelial cell (EC) dysfunction and vascular integrity disruption, are involved, as well as increases in inflammatory cell numbers, the production of cytokines, the proliferation and migration of vascular smooth muscle cells (VSMCs), the activation of monocytes and macrophages, and neovascularization. Pathological biomechanical and haemodynamic changes (e.g., oxidative damage, shear stress) result in these events, which are closely correlated with plaque stability. 1 EC dysfunction has been observed in atherosclerotic lesions in both humans and animals and eventually leads to apoptosis and the development of atherosclerosis. 2, 3 Endothelial dysfunction leads to proinflammatory activation, generates autocrine, and paracrine signaling loops, and influences other type of cells that are involved in atherogenesis. 4 EC apoptosis occurs throughout the early stages of atherosclerosis and plays important roles in plaque regression and plaque instability, 5, 6 which are caused by various factors, particularly by oxidized low-density lipoprotein (ox-LDL). 1, 7 Thus, inhibition of EC apoptosis may be a useful therapeutic strategy for ameliorating plaque instability. Dickkopf1 (DKK1), a secretory glycoprotein, can block the Wnt pathway by competitively binding to receptors (e.g., LRP5/6, Kremen) on the cell membrane. 8 Ueland et al. found that DKK1 expression was stronger in von Willebrand factor (vWF)-positive ECs and in CD68-positive macrophages than in other areas of plaques. 9 They also found that DKK1 participated in platelet-induced EC activation, indicating that DKK1 promotes inflammation in atherosclerotic plaques and is an atherogenic factor. 9 In a previous clinical study of patients with ACS, we found that DKK1 plasma levels were not only correlated with disease severity but also served as a prognostic predictor. Thus, DKK1 concentration may reflect the severity and stability of coronary atherosclerosis. 10 Several studies have indicated that DKK1 plays an important role in atherosclerosis; however, the underlying mechanisms have yet to be elucidated. Furthermore, the knockout mouse is not an ideal model for DKK1 research in disease, because the homozygous DKK1 (− / − ) mutation is lethal. 11 Therefore, in this investigation, we used a lentivirus to overexpress or silence DKK1 in ApoE − / − mice.
A previous study found a strong association between endoplasmic reticulum stress (ERS) markers, such as CCAAT/ enhancer-binding protein-homologous protein (CHOP) and glucose-regulated protein 78 (GRP78), and the presence of atherosclerotic plaques in human coronary artery lesions, suggesting that ERS is involved in the development of plaque instability in humans. 12 Disrupting the secretion of Wnt5a, a Wnt pathway agonist, has been shown to induce ERS in mammalian cells, indicating that a correlation exists between Wnt secretion and ERS. 13 DKK1 is an important regulator of the Wnt pathway, 8 yet, its role in ERS-associated apoptosis in atherosclerosis remains unclear.
On the basis of these findings, we hypothesized that DKK1 promotes plaque formation and instability in part by stimulating EC apoptosis. To accomplish this, we investigated the effect of modulated DKK1 expression on atherosclerosis plaques in ApoE − / − mice and EC apoptosis; and explored the underlying mechanisms in endothelial cells using human umbilical vein endothelial cells (HUVECs).
Results

DKK1
influenced the formation and vulnerability of aortic plaques and caused vascular endothelium dysfunction in ApoE − / − mice. Intense GFP staining was observed in aortic plaques and carotid artery plaques (Figure 1b) . The results of Western blotting to reveal aorta-containing proteins, immunohistochemistry and analysis of plasma DKK1 further demonstrated that DKK1 protein expression was significantly lower in the shDKK1 group and higher in the DKK1 group than in the NS and GFP groups (Figures 1c-f) , which established that overexpression and silencing vectors were effective.
Endomucin is a marker for endothelial cells, 14 and MOMA-2 is a marker for monocyte-macrophage. 15 Similar to the findings of a previous study, 9 atherosclerotic lesions in the aortic plaques in the ApoE − / − mice showed strong DKK1 expression in all endomucin-positive ECs and in small regions containing MOMA-2-positive macrophages (Figure 1g ). Colocalization immunofluorescence staining further confirmed that the majority of DKK1 was expressed in ECs other than smooth muscle cells and macrophages.
Vascular endothelium dysfunction plays an important role in atherosclerosis. When the mice were fed atherogenic chow for 4 weeks, the shDKK1 group showed recuperative acetylcholine-induced endothelium-dependent relaxation in the thoracic aorta ring after pre-contraction with norepinephrine, whereas the DKK1 group showed damaged endothelial relaxation (Supplementary Figure 1) .
In mice fed atherogenic chow for 12 weeks, both the en face lesion areas and the cross-section lesion areas measured in the aortic root were decreased in the shDKK1 group and increased in the DKK1 group compared with the areas in the NS and GFP groups (Figures 2a-c) .
In both aortic ( Figure 2d ) and carotid ( Figure 2h ) plaques, the relative content of VSMCs and collagen fibers were lower in the DKK1 group but higher in the shDKK1 group than in the NS GFP groups. Conversely, the relative contents of macrophages and lipids were higher in the DKK1 group but lower in the shDKK1 group than in the NS and the GFP groups. Accordingly, the plaque vulnerability index was higher in the DKK1 group but lower in the shDKK1 group. Moreover, fibrotic cap thickness was substantially lower in the DKK1 group and higher in the shDKK1 group than in the NS and the GFP groups (Figures 2d and g ). Although plaques were completely filled in most carotid arteries, except in the shDKK1 group, the carotid plaques were shown the similar trend (Figures 2h-j) . Moreover, vascular outward remodeling was more significant in the DKK1 group than in the other groups (Figure 2k ). In mice fed atherogenic chow for 4 or 8 weeks, the shDKK1 group displayed substantially increased fibrous caps of plaque, while the DKK1 group showed increased plaque size and vulnerability (Supplementary Figure 2) . DKK1 can aggravate plaque vulnerability not only during the short-term feeding of atherogenic diet, but also in the long-term atherogenic diet. These results reveal that DKK1 augments plaque formation and instability in both aortic and carotid plaques and that silencing DKK1 attenuates these effects.
DKK1-induced inflammatory factors and apoptosis in aortic atherosclerotic plaques in ApoE − / − mice. Several studies showed that inflammation and apoptosis contribute to the instability of atherosclerotic plaques. 1 The content of inflammatory factors (e.g., IL-6, IL-1β, MCP-1, and TNF-α) was lower in the shDKK1 group and higher in the DKK1 group (Po0.05, Figure 3a) .
Expression of the anti-apoptotic factor Bcl-2 was significantly upregulated in the shDKK1 group, while expression of the pro-apoptotic factor Bax and cleaved caspase-3 was significantly downregulated compared to the NS and GFP groups (Po0.05, Figure 3b ). The opposite results were found in the DKK1 group (Po0.05, Figure 3b ).
The percentage of TUNEL (+) cells was lower in the shDKK1 group and higher in the DKK1 group than in the NS and GFP groups (Po0.05, Figures 3c and d) . The percentage of TUNEL (+) endomucin (+) cells showed a similar trend (Po0.05, Figure 3e) . Accordingly, the results from immunofluorescence analysis and TUNEL assay co-localization revealed that DKK1 promoted apoptosis in atherosclerotic plaques, mostly due to its effects on ECs.
DKK1 expression was upregulated following ox-LDL treatment in a time-and concentration-dependent manner, and interference of DKK1 inhibited ox-LDL-induced apoptosis in HUVECs. Oxidized low-density lipoprotein (ox-LDL) may play a pre-eminent function in atherosclerotic lesion formation. 16 So in vitro, we used ox-LDL to mimic the stimulation to the endothelial cells during atherosclerosis. HUVECs treated with ox-LDL (150 μg/ml) for various lengths of time (0 h, 0.5 h, 1 h, 3 h, 6 h, or 12 h) exhibited time-dependent increases in DKK1 protein and mRNA levels as well as in DKK1 levels in the culture supernatant. DKK1 expression gradually increased at the mRNA level starting from 1h, at the protein level starting from 3h, and in the culture supernatant from 6h (Po0.05, Figures 4a-c) . HUVECs treated for 6 h with various concentrations of ox-LDL (0, 25, 50, 100, 150, or 200 μg/ml) exhibited concentration-dependent increases in DKK1 mRNA and protein expression and in DKK1 levels in the culture supernatant. DKK1 expression was consistently significantly higher in cells 
DKK1-induced apoptosis in HUVECs by activating ERS.
We next monitored changes in the expression of caspase-12, which is considered to be a marker of ERS-associated apoptosis in mice. Caspase-12 expression was reduced in the shDKK1 group and enhanced in the DKK1 group (Po0.05, Figure 3a ). To further investigate whether DKK1-induced Dickkopf1 destabilizes atherosclerotic plaques M Di et al apoptosis through ERS, we treated cells with 4-phenylbutyric acid (4-PBA), an ERS inhibitor. 17 Treatment with 4-PBA significantly attenuated the increase in cleaved caspase-3 expression and the decrease in the Bcl-2/Bax ratio observed in rDKK1-stimulated HUVECs (Po0.05, Figure 5a ) or lenti-DKK1-transfected HUVECs (Po0.05, Supplementary  Figure 3a) . Notably, the TUNEL assay and flow cytometry results were consistent with those obtained by Western blotting (Po0.05, Figures 5b-e) . In summary, we demonstrated that DKK1 induces apoptosis partly via the ERS pathway both in vivo and in vitro.
We also examined the effect of DKK1 on ERS. First, cells transfected with DKK1 siRNA were confirmed to have reduced DKK1 expression relative to cells transfected with NC siRNA. In contrast, cells were treated with ox-LDL or rDKK1 to induce the overexpression of DKK1. To determine whether ox-LDL activates ERS through DKK1, we monitored changes in the levels of eukaryotic initiation factor 2α (eif2α), CHOP, inositol-requiring enzyme 1 (IRE1), sliced X-box-binding protein 1 (XBP1s), transcription factor 6 (ATF6), and GRP78, 18 which are considered markers of ERS. 19 All of these markers showed significantly increased protein Figure 4a ). In addition, siRNA-mediated silencing of DKK1 reversed ox-LDL-induced ERS (Po0.05, Supplementary Figure 4b) . On the basis of these findings, we concluded that DKK1 may induce apoptosis in ox-LDL-treated HUVECs partly via ERS.
DKK1-induced ERS-associated apoptosis through IRE1α and eif2α/CHOP. We have monitored that DKK1 induced the level of eif2α, CHOP, IRE1, XBP1s, ATF6, and GRP78 in HUVECs. To identify the components playing a main role in DKK1-induced, ERS-associated apoptosis, we transfected HUVECs with NC siRNA, CHOP siRNA, or IRE1α siRNA prior to treatment with rDKK1 or transfection with lenti-DKK1. 20 To further verify the role of eIF2α in DKK1-mediated effects, we also treated cells with salubrinal, which specifically inhibits ERS by preventing eIF2α dephosphorylation. [21] [22] [23] Salubrinal significantly attenuated the increased cleaved caspase-3 expression and decreased Bcl-2/Bax expression in rDKK1-stimulated HUVECs (Po0.05, Figure 7a ) and lenti-DKK1 transfected HUVECs(Po0.05, Supplementary Figure 3d) . Moreover, the flow cytometry and TUNEL assay results were consistent with those obtained by Western blotting (Po0.05, Figures 7b-e) . Generally, DKK1-induced apoptosis via IRE1α and eif2α/CHOP signaling, independent of other ERS transducers.
DKK1-induced ERS-associated apoptosis through activation of the JNK pathway and inhibition of Wnt/β-catenin signaling. We transfected cells with DKK1 siRNA to downregulate DKK1 and infected cells with lentivirus to overexpress DKK1. Western blotting revealed that DKK1 activated JNK, while knockdown of DKK1 led to a decrease in JNK phosphorylation (Po0.05, Supplementary  Fig.5a-5b ). To further verify the effect of JNK pathway on ER stress and apoptosis, we pretreated HUVECs with the JNK inhibitor-SP600125 significantly reversed the upward trend in GRP78 and CHOP protein expression observed in HUVECs transfected with lenti-DKK1 (Po0.05, Figure 8a ). These data indicate that DKK1 induces apoptosis and ERS in HUVECs by targeting and upregulating JNK. Furthermore, Bcl-2 expression increased significantly in lenti-DKK1-transfected HUVECs that were pretreated with SP600125, while Bax expression decreased.
IM-12 activates canonical Wnt signaling, 24 whereas FH535 acts as an inhibitor of canonical Wnt signaling. 25 To verify the effect of the canonical Wnt signaling pathway on apoptosis and ERS, we pretreated HUVECs with IM-12 or FH535. HUVECs with pretreated IM-12 significantly reversed the upward trend in GRP78 and IRE1α protein expression in HUVECs transfected with lenti-DKK1 (Po0.05, Figure 8d ), while HUVECs with pretreated FH535 reverted the decrease in GRP78 and IRE1α protein expression in HUVECs transfected with DKK1 siRNA (Po0.05, Figure 8e) . However, the protein levels of JNK and CHOP were not changed in IM-12 or FH535.
Discussion
This is the first study to describe how DKK1 affects plaque formation and stability in atherosclerosis in ApoE − / − mice, which was accomplished by using lentivirus-mediated silencing and overexpression of the DKK1 gene.The following conclusions were generated: (1) The overexpression of DKK enlarged and destabilized atherosclerotic lesions and increased apoptosis, while inhibition of DKK1 expression hold the formation and vulnerability of atherosclerotic plaques in the whole progression of atherosclerosis; (2) treatment with ox-LDL induces DKK1 expression in HUVECs in a time-and concentration-dependent manner; (3) DKK1 induces ERS through IRE1α and eif2α/CHOP, leading to apoptosis; and (4) DKK1 activates ERS via both the JNK pathway and canonical Wnt signaling.
Our results show that DKK1 dose not influence the circulating levels of total cholesterol, LDL-C or blood glucose (Supplementary Table 1) . Classical pathological studies have demonstrated that plaque components, inflammation factors and apoptosis play important roles in modulating the stability of atherosclerotic plaques. [26] [27] [28] We found that DKK1 silencing reduced macrophage accumulation and increased VSMC numbers in plaques, while DKK1 overexpression augmented plaque vulnerability during the entire process of atherosclerosis.
DKK1 is an antagonist of the Wnt signaling pathway.
29-32
Ueland et al. 9 found that DKK1 contributes to the activation of ECs by platelets. In a previous clinical study of patients with ACS, DKK1 plasma levels not only correlated with disease severity but also served as a prognostic predictor of disease, suggesting that DKK1 levels reflect coronary atherosclerosis stability. 10 In two previous investigations conducted by our group, we found that treatment with ox-LDL promotes DKK1 expression in macrophages, resulting in inhibiting the accumulation of lipids 33 and that oscillatory shear stress can induce DKK1 expression in ECs through PAR1/CREB. 34 Both of these biomechanical and haemodynamic factors contribute to the development and destabilization of atherosclerosis. In earlier research, we used a partial carotid ligation model to imitate and induce disturbed flow and acute endothelial injury. 34, 35 Differ from it, we used constrictive silica collars to accelerate atherosclerotic lesion formation. 36 And we observed the lesion on both right carotid artery and aorta root 12 weeks' atherogenic chow after collar surgery. Thus, in the present study, we demonstrated the negative effects of DKK1 on the formation and instability of atherosclerotic plaques.
In this study, we also observed that the expression of inflammatory factors (e.g., IL-6, IL-1β, TNF-α, and MCP-1) decreased in conjunction with the downregulation of DKK1 and increased with upregulation of DKK1. Accumulation of inflammatory factors may induce monocyte recruitment and adhesion to the activated endothelial layer, thereby aggravating plaque instability. 6, [26] [27] [28] Several studies have reported that the exogenous inhibition of DKK1 reduced IL-1β and TNF-α expression, significantly inhibited TNF-α expression in macrophage sand chondrocytes stimulated by lipopolysaccharide, 37 attenuated angiogenesis, 38 and decreased monocyte adhesion to HUVECs. 39 DKK1 has also been shown to affect MMP-3 expression and influence collagen degradation in cartilage. 40 Furthermore, DKK1 upregulation increases neovascularization. 41 Thus, DKK1 may lead to plaque instability by augmenting inflammation, adhesion, collagen degradation and neovascularization.
In addition, we found that inhibition of DKK1 expression can attenuate cleaved caspase-3 expression as well as apoptosis. As a major regulator of the Wnt signaling pathway, DKK1 induces cellular apoptosis in many diseases. [29] [30] [31] [32] Overexpression of DKK1 sensitizes cells in brain tumors, 42 renalcell carcinoma and thyroid cancers 43, 44 to apoptosis. Weng et al. discovered that DKK1 expression is closely correlated with the expression of pro-apoptotic factors (e.g., Bad and caspase-3) in osteoarthritis and inhibition of DKK1 expression reduced caspase-3 cleavage and alleviated chondrocyte apoptosis by reducing Bax expression and increasing Bcl-2 expression. 40, 45 Cellular apoptosis is ubiquitous in vulnerable plaques; as such, recent studies on vulnerable plaques have mostly focused on inflammation and cellular apoptosis. Multiple pathophysiological factors, both systemic and localized to the arterial walls, can disturb ER function in ECs, VSMCs, and macrophages during the initiation and progression of atherosclerosis. 46 Expression of ERS activation markers has been observed in atherosclerotic lesions in humans and animals. 47 Importantly, ERS-associated apoptosis is correlated with plaque instability and the clinical progression of atherosclerosis. CHOP is only robustly expressed in "vulnerable" plaques that show evidence of lesions and apoptosis. 47 Moreover, Cominacini et al. revealed that persistent ERS is related to abnormal numbers of apoptotic cells in vulnerable plaques. 37 Consistent with these findings, our results showed that inhibition of DKK1 expression remarkably reduced the expression of ERS-associated apoptotic markers (e.g., caspase-12) in ApoE − / − mice. Another study found that disrupting the secretion of human Wnt5a, a Wnt pathway agonist, induced ERS in mammalian cells, revealing a correlation between Wnt secretion and ERS. 13 Our results indicate that DKK1 induces ERS and facilitates apoptosis in atherosclerosis.
In our study, ECs were found to be important sources of DKK1, as demonstrated by the co-localization of DKK1 with endomucin, an EC marker, in atherosclerotic lesions in ApoE − / − mice, which was in accord with the previous investigation. 9 Interestingly, the observed areas of endomucin-positive ECs localization were almost equivalent to those that were stained positive for DKK1. Thus, even though DKK1 is expressed in different cell types, endothelial cells presumably played the most important roles other than smooth muscle cells and macrophages. While many different cells participate in ACS, 48 apoptosis of ECs is a key event in the initiation of atherosclerotic plaque formation 47 and the progression to advanced atherosclerosis, which is vulnerable to rupture. 3, 6, 7, [49] [50] [51] We found that both SMCs and macrophages take up the GFP-labeled DKK1 from co-cultured ECs (Supplementary Figure 6a) . In previous studies, recombinant DKK1 blocked the proliferation of VSMCs 52 and inhibited foam cell formation in macrophages. 33 Besides, inhibition of DKK1 expression can attenuate the inflammation of macrophages (Supplementary Figure 6b-c) .Thus, the effects of DKK1 in promoting the dysfunction and apoptosis of endothelial cells may be the "starting point" of DKK1's effects on cross-talk with other cells in atherogenesis. ADMA 53 and ET-1 54 are markers of endothelial cell dysfunction. In our study, we also found that ADMA and ET-1 were positively correlated with DKK1 levels in plasma from healthy controls, unstable angina pectoris and acute myocardial infarction patients (Po0.05, Supplementary Figure 7) . Therefore, we focused on ECs to experimentally determine the function of DKK1 in vitro.
Inhibition of DKK1 expression decreased ox-LDL-induced apoptosis and ERS in HUVECs. Prolonged and unresolvable ERS is known to induce apoptosis. 55, 56 In particular, ERS promotes EC apoptosis via caspase-12 and the mitochondrial pathway. 57, 58 ERS has also been induced in ECs via pathological shear stress, 59 hypoxia, 18, 57, 58 and increased GRP78, CHOP and caspase-12 expression. Here, for the first time, we showed that ox-LDL treatment activates ERS apoptosis via the JNK pathway, thereby promoting HUVECs apoptosis.
Numerous studies have shown that different cell types have specific ERS components; however, the effect of these variations on EC apoptosis is unclear. In 2005, Boyce et al. 21 reported that salubrinal, a selective inhibitor of eif2α dephosphorylation, protects cells from ERS. In the present study, we used salubrinal, CHOP siRNA and IRE1α siRNA to inhibit various components associated with ERS and to investigate the role of eif2α, CHOP and IRE1α in ERS-associated apoptosis. Ultimately, we found that DKK1-induced ERSassociated apoptosis via IRE1α and eif2α/CHOP signaling. DKK1 is an antagonist of the canonical Wnt signaling pathway. We also found DKK1 can influence GRP78, IRE1α and apoptosis factors through Wnt/β-catenin signaling. However, Wnt/β-catenin signaling did not change the protein levels of JNK and CHOP.
In conclusion, inhibition of DKK1 expression effectively decrease plaque stability by attenuating ERS-mediated cellular apoptosis through intiating the JNK pathway and inhibiting Wnt/βcatenin. Moreover, the IRE1α and eif2α/CHOP pathways were found to participate in the activation of ERS. However, the mechanism underlying the augmentations of ERS by DKK1 remains to be determined. Notably, lentiviruses have low specificity in vivo. Therefore, in future experiments we will use EC-specific DKK1 KO mice and macrophagespecific DKK1 KO mice to determine the exact role of DKK1 in atherosclerosis through its action on various cell types. Although our data are preliminary, these findings might lead to new and promising methods for the treatment of atherosclerosis. Atherosclerosis animal model protocol. A total of 120 ApoE − / − mice (eight-week-old males) were purchased from the Peking University Animal Research Center (Beijing). All mice were fed atherogenic chow (i.e., a high-fat diet with 0.25% cholesterol and 15% cocoa butter) (Figure 1a ). The atherosclerotic model was created as previously described. 33 We applied constrictive silica collars to the right carotid artery (RCA) to accelerate atherosclerotic lesion formation and investigated size, components, and vulnerability index in both aortic and carotid plaques. Pentobarbital sodium was used for anesthesia via intraperitoneal injection (40 mg/kg) when placing the constrictive collars. The mice were randomly divided into four groups (n = 30 each): a normal saline group (NS), an empty lentivirus group (GFP), a DKK1i lentivirus group (shDKK1), and a DKK1 lentivirus group (DKK1). Eight weeks after the surgery, a 200 μl suspension (4*10 8 TU DKK1i or DKK1 lentivirus per ml) was injected into each mouse through the tail vein. The mice were killed 4 weeks post-transfection using pentobarbital sodium (50 mg/kg, i. p.) before exsanguination by perfusion via the abdominal aorta with PBS.
Cell culture. HUVECs were obtained from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultivated in endothelial cell medium (ECM) (ScienCell, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/ streptomycin at 37°C in 5% CO 2 . Cells from passages 4 to 8 were used for experiments. THP-1 cells obtained from the American Type Culture Collection (ATCC) .160 nM phorbol myristate acetate (PMA) was used overnight for THP-1 cell differentiation into macrophages.
Lentiviral silencing and overexpression-vector construction. To generate a lentivirus-mediated silencing vector, the lentivirus vector pGLV3/H1/GFP +Puro (pGLV3) was purchased from GeneChem (Shanghai, China), and a short-hairpin RNA sequence targeting DKK1 and or scrambled control RNA, was cloned into the vector. The following duplexes targeted murine DKK1: sense 5′-TCACCATCAAGCCAGCAAT-3′; antisense 5′-TCACCATCAAGCCAGCAAT-3′.
To achieve lentivirus-mediated DKK1 overexpression, the lentiviral vector LV5 was purchased from GenePharma Co., Ltd. (Shanghai, China), and the full-length coding sequence of either human or mouse DKK1 C-terminally tagged with green fluorescent protein (GFP) was cloned into the vector. A vector cloned with GFP alone was used as a negative control (NC).
siRNA and RNA interference. Upon reaching 40-60% confluence, HUVECs were transfected with specific siRNA or negative control siRNA (GenePharma, Shanghai, China) (shown in Supplementary Table 1) using Lipofectamine 3000 (Thermo Fisher Scientific, Waltham, MA, USA) in Opti-MEM (Gibco, Thermo Fisher Scientific, Waltham, MA, USA). After 6 h of transfection, the medium was replaced with complete ECM, and the cells were cultured for an additional 24 h. The transfected cells were treated with ox-LDL, recombinant DKK1 Dickkopf1 destabilizes atherosclerotic plaques M Di et al (rDKK1) or lentivirus DKK1 at the designated concentrations and for the indicated times.
Biochemical measurements. The mice were fasted overnight. Blood samples were collected and centrifuged. Serum levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol and blood sugar were measured via enzymatic assay using an automatic biochemical analyser (Roche Cobas Integra 800, Basel, Switzerland).
Histopathology and immunohistochemistry. The whole aorta, the aortic root and the RCA were dissected, removed, fixed in 4% formaldehyde overnight at 4°C, embedded in OCT compound, prepared into 5-μm-thick sections. The cryosections were stained with haematoxylin and eosin for plaque morphology, oil red O for lipids, picrosirius red for collagen and Masson's trichrome staining for fibrous cap. After blocking in 5% bovine serum albumin (BSA) in PBS, the sections were incubated with primary antibodies (shown in Supplementary Table 2) overnight at 4°C and then with an HRP Detection System (ZSGB-BIO, Beijing, China). Detection was subsequently performed using DAB (3, 3′-diaminobenzidine) (ZSGB-BIO). Plaques stained with picrosirius red were viewed under polarized light. The areas of collagen, VSMCs, extracellular lipid deposits and macrophages were recorded as the percentage of positive area divided by the plaque area in 20 highpower fields (20*). The vulnerability index was calculated using the following formula: (macrophage staining%+lipid staining%)/(VSMC staining%+collagen staining%). 60 Staining in the plaque was quantified using Image-Pro Plus 6.0 software (Media Cybernetics, Rockville, MD, USA) and a colour CCD video microscope (OLYMPUS, Tokyo, Japan).
Immunofluorescence staining and microscopy. The cryosections were blocked with 1% BSA and incubated with primary antibodies (shown in Supplementary Table 2) at 4°C overnight. The sections were washed with PBS, and incubated with FITC-or TRITC-conjugated secondary antibodies. Nuclei were stained with 4′, 6-diamidino-2-phenylindole (DAPI; 1:2000, Roche, Mannheim, Germany) for 5 min. The samples were rinsed three times in PBS, and were examined under an epifluorescence microscope, and data were analyzed using Image-Pro Plus 6.0 software (Media Cybernetics).
Aortic ring experiments in vitro. Thirty ApoE − / − mice were injected NS, DKK1i or DKK1 lentivirus respectively. The mice were killed 2 weeks after transfection. The thoracic aortic rings 2-3 mm in depth that included the entire endothelium were cut and mounted in a 620 M Multi myograph system (DMT, Aarhus, Denmark) containing 10 ml of Krebs bicarbonate solution maintained at 37°C. After standardization, norepinephrine (10 −5 M) was added to the bath to precontract the aortic ring, and stabilize for 5 min. Ach (10 , 10 −5 M) was successively added to the chamber to test for endothelial relaxation. The relaxation responses were calculated as a percentage of the norepinephrine pre-contraction. All the data were collected using Powerlab software (AD Instruments, Bella Vista, NSW, Australia).
Western blot analysis. HUVECs and tissue samples were lysed using RIPA buffer containing 1 mM phenylmethylsulfonyl fluoride (Invitrogen, Carlsbad, CA, USA) and collected by centrifugation at 14 000 × rpm for 10 min. Equal amounts of proteins and pre-stained protein ladder (Thermo Fisher Scientific) were separated on 10% SDS-PAGE gels, transferred to methanol-activated polyvinylidene fluoride membranes with a 0.45 μm pore size (Millipore, Billerica, MA, USA), and incubated with primary antibodies overnight at 4°C. The membranes were incubated with secondary antibodies (ProteinTech, Rosemont, Penn., USA) the next day for 1 h 20 min at room temperature. Bands were visualized using Immobilon ECL substrate (Millipore, Billerica, MA, USA), and blots were imaged with an LAS-4000 luminescent image analyser (Fujifilm USA, Valhalla, NY, USA). Protein expression was quantified using Adobe Photoshop CS6 (Adobe Systems, San Jose, CA, USA), normalized to the β-actin expression in each sample, and expressed as a percentage of the control. The primary antibodies used in the experiments are shown in Supplementary Table 2 .
RNA extraction and quantitative real-time PCR. Total RNA was extracted from HUVECs using TRIzol reagent (Ambion, Life Technologies, Waltham, MA, USA), and it was reverse-transcribed into cDNA using a PrimeScript RT Reagent Kit (TakaRa Biotechnology, Dalian, China). The cDNA (1 ng) was subjected to Q-PCR using SYBR Green (TakaRa Biotechnology) for the relative quantification of mRNA expression. Quantification was accomplished using the 2-ΔΔCt method. β-actin was used to normalize mRNA levels. The reverse-transcription primer sequences used for the target genes are shown in Supplementary Table 2.
ELISAs Kit. The level of DKK1 in mice plasma were determined using a mouse DKK1 ELISA Kit (R&D, Minneapolis, MN, USA). The level of DKK1 in cell supernatant and human plasma was assessed using a human DKK1 ELISA Kit (R&D). Other protein levels were determined using the following ELISA kits: ADMA ELISA Kit (BlueGene Biotech, Shanghai, China), ET-1 ELISA Kit (BlueGene Biotech). All kits were used according to the manufacturer's protocol. The analysis was completed at a wave-length of 450 nm (with reference of 570 nm) in an ELISA plate reader.
Flow cytometry. Cell apoptosis was analyzed using an Annexin V PE/7-Amino-Actinomycin (7-AAD) Apoptosis Detection Kit (BD Pharmingen, San Diego, CA, USA) according to the manufacturer's protocol. The following groups were used to set up compensation and to define quadrants: unstained control cells, cells stained with PE Annexin V (no 7-AAD), and cells stained with 7-AAD (no PE Annexin V). Apoptotic cells were examined using a flow cytometer (BectonDickinson, USA) within 1 h, and the percentage of early apoptotic cells (upper-right quadrant) was measured using FlowJo software (Tree Star, Ashland, OR, USA).
In situ detection of apoptotic cells. Apoptotic cells and apoptotic ECs in aortic root cryosections were determined using an In Situ Apoptosis Fluorescein Detection Kit (Millipore, Billerica, MA, USA).
Statistical analysis. Data were analyzed using SPSS v16.0 (SPSS Inc., Chicago, IL, USA). Data are presented as the mean ± S.D. of at least three independent experiments. Normality of variables distribution was tested by the Kolmogorov-Smirnov test. Comparisons were analyzed using Student's t-test or one-way ANOVA followed by Bonferroni post hoc test. Po0.05 was considered statistically significant.
